We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Blood Test for Clinical Depression Administered in Minutes

By LabMedica International staff writers
Posted on 07 Jun 2011
A blood test for depression has been simplified and it could contribute to early detection of the condition if performed during regular medical checkups.

According to Human Metabolome Technologies (Tsuruoka, Japan), clinical depression can be detected by measuring the concentration of phosphoric acid in blood. The company did a comparative study of 66 people--31 patients diagnosed with depression at the National Center of Neurology and Psychiatry in Kodaira, (Japan) and 35 healthy test subjects of similar age and gender.

Using the concentration of ethanolamine phosphate as a diagnostic tool, the investigators were able to identify the clinically depressed patients 82% of the time. They deduced that subjects came from the healthy group 95% of the time.

Human Metabolome Technologies is developing a reagent to determine the level of ethanolamine phosphate in minutes. The company expects to complete the reagent in a year. Several other methods of diagnosing depression using blood tests under development involve analysis of about 20 different types of white-blood cell DNA, a time-consuming process.

Details of the new testing regimen were discussed at a conference of the Japanese Society of Biological Psychiatry in Tokyo (Japan) on May 22, 2011.

Related Links:

Human Metabolome Technologies




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automated Staining Unit
RAL Stainer

Latest Clinical Chem. News

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
07 Jun 2011  |   Clinical Chem.

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
07 Jun 2011  |   Clinical Chem.

Low-Cost Portable Screening Test to Transform Kidney Disease Detection
07 Jun 2011  |   Clinical Chem.